Published in Gastroenterology on April 01, 1981
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut (1985) 1.28
Clostridium difficile and inflammatory bowel disease. Gut (1983) 1.20
Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci (2009) 1.14
The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therap Adv Gastroenterol (2013) 1.00
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome. PLoS Comput Biol (2015) 0.99
Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol (2010) 0.97
Clostridium difficile-associated pouchitis. Dig Dis Sci (2006) 0.93
Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol (2008) 0.86
Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. Nat Rev Gastroenterol Hepatol (2009) 0.83
Crohn's disease and infections: a complex relationship. MedGenMed (2004) 0.80
Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease. West J Med (1983) 0.76
Clostridium difficile colitis in children with cystic fibrosis. Dig Dis Sci (2004) 0.76
Clostridium difficile, sulphasalazine, and ulcerative colitis. Postgrad Med J (1987) 0.75
Clostridium difficile and inflammatory bowel disease: implications for current clinical practice. F1000 Med Rep (2009) 0.75
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med (1993) 7.85
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell (2000) 3.65
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Immunophysiology of experimental food allergy. Mucosal Immunol (2008) 2.76
Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows. Nature (2010) 2.71
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA (1987) 2.47
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91
Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA (2000) 1.88
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene (1995) 1.83
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol (1997) 1.80
The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol (1996) 1.75
Management of Crohn's disease in adults. Am J Gastroenterol (1997) 1.65
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Human malignant T cells capable of inducing an immunoglobulin class switch. J Exp Med (1985) 1.56
Evaluation of the clinical efficacy of erythromycin, amoxicillin and co-trimoxazole in the treatment of acute respiratory tract infections in paediatric patients. Curr Med Res Opin (1982) 1.56
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Perpetuation of published medical errors. Lancet (1993) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
The use of 6-mercaptopurine in adolescents. Gastroenterology (1991) 1.40
Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol (1997) 1.39
CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol (2009) 1.39
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Unusual fermentative, gram-negative bacilli isolated from clinical specimens. I. Characterization of Erwinia strains of the "lathyri-herbicola group". Appl Microbiol (1970) 1.35
Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology (1992) 1.34
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Basidiomycetous (mushroom) infection of the maxillary sinus. Otolaryngol Head Neck Surg (1990) 1.33
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med (1993) 1.31
Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc Natl Acad Sci U S A (1989) 1.30
Infection due to Actinobacillus actinomycetemcomitans. Am J Clin Pathol (1971) 1.30
The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol (1998) 1.29
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
Comparison of direct and concentrated acid-fast smears to identify specimens culture positive for Mycobacterium spp. J Clin Microbiol (1999) 1.28
Infections caused by microorganisms of the genus Erwinia. Ann Intern Med (1972) 1.27
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis (1997) 1.25
Q fever in maritime Canada. Can Med Assoc J (1982) 1.25
Endocarditis caused by Lactobacillus plantarum. Ann Intern Med (1973) 1.25
Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest (1984) 1.23
Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and pigment epithelium. Invest Ophthalmol Vis Sci (1979) 1.23
Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr (1995) 1.23
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Opacification of Middlebrook agar as an aid in identification of Nocardia farcinica. J Clin Microbiol (1993) 1.21
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther (1996) 1.21
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
FURTHER STUDIES IN OSTEOGENESIS. Ann Surg (1919) 1.19
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses (1993) 1.17
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
T-cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology (1993) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol (1991) 1.14
Erwinia and yellow-pigmented Enterobacter isolates from human sources. Antonie Van Leeuwenhoek (1971) 1.14
Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J Exp Med (1994) 1.14
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Science (1984) 1.14
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med (1989) 1.13
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Systemic amyloidosis complicating inflammatory bowel disease. Gastroenterology (1997) 1.10
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology (1996) 1.09
Association of mucoid encapsulated Moraxella duplex var. nonliquefaciens with chronic bronchitis. Appl Microbiol (1968) 1.09
Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy (2008) 1.09
Genetic determinants of microbial resistance to antibiotics. Rev Infect Dis (1989) 1.09
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07